Linda M Rubinstein's Net Worth
$1.08 Million
Who is Linda M Rubinstein?
Linda M Rubinstein has an estimated net worth of $1.08 Million. This is based on reported shares across multiple companies, which include Alector, Inc., BIOCEPT INC, Adverum Biotechnologies, Inc., FIVE PRIME THERAPEUTICS INC, and Solexa, Inc..
SEC CIK
Linda M Rubinstein's CIK is 0001321937
Past Insider Trading and Trends
2006 was Linda M Rubinstein's most active year for acquiring shares with 8 total transactions. Linda M Rubinstein's most active month to acquire stocks was the month of November. 2006 was Linda M Rubinstein's most active year for disposing of shares, totalling 14 transactions. Linda M Rubinstein's most active month to dispose stocks was the month of November. 2005 saw Linda M Rubinstein paying a total of $1,010,760.00 for 166,000 shares, this is the most they've acquired in one year. In 2006 Linda M Rubinstein cashed out on 179,998 shares for a total of $2,280,941.60, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Alector, Inc. (ALEC) Snapshot price: $4.85
Interim Chief Financial Ofcr
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
BIOCEPT INC (BIOCQ) Snapshot price: $0.01
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Adverum Biotechnologies, Inc. (ADVM) Snapshot price: $6.76
CHIEF FINANCIAL OFFICER
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 3
| |||
Form 4
|
∞
| 100K |
$1.45 | $145,490.00 | 100K |
Jun 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
FIVE PRIME THERAPEUTICS INC No price found
Interim CFO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Solexa, Inc. No price found
VP and CFO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 26
| |||
Form 4
|
—
|
0
|
$10.06 | -$97,072.40 |
0
|
Dec 14 - Dec 15
| |||
Form 4
|
—
|
0
|
$9.48 | -$456,785.62 |
0
|
Dec 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |